WednesdayOct 26, 2022 2:29 pm

TinyGemsBreaks – Knightscope Inc. (NASDAQ: KSCP) Robot Show Takes the Spotlight in Houston, Texas

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), has announced that its Robot Roadshow will land at EastGroup Properties, 3955 World Houston Pkwy, in Houston, Texas, on Oct. 27, 2022. The Robot Roadshow is an engaging experiential event designed to grab attention, forge direct connections with potential clients, and strike up conversations in a compelling fashion. The announcement reads, “The Houston Roadshow landing will be guided by Knightscope experts, and visitors will be able to interact directly with each of the ASRs and see the Knightscope Security Operations Center (‘KSOC’) user interface in action. Clients, investors and…

Continue Reading

WednesdayOct 26, 2022 12:41 pm

TinyGemsBreaks – QSAM Biosciences Inc. (QSAM) Announces Approval of Second Clinical Trial Site for Phase 1 Study

QSAM Biosciences (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP, or CycloSam(R), for the treatment of bone cancer and related diseases, has added Rutgers Cancer Institute of New Jersey (“RCINJ”) as a clinical trial site for its phase 1 CycloSam study. RCINJ has been approved to begin enrolling patients into the study, which will evaluate the effectiveness of CycloSam in treating patients with bone cancer. According to the announcement, RCINJ is part of Rutgers Health and is New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, a designation granted to institutions based on scientific leadership, resources and track record of…

Continue Reading

WednesdayOct 26, 2022 12:05 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Official Start of the Demonstrator US Tour for Its FIVE EV Crossover

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the beginning of the Mullen FIVE Strikingly Different EV Crossover Tour, which will commence on Oct. 27 in Pasadena, California. Due to overwhelming interest, the tour has been expanded to add new dates of Nov. 1 and 2 at Angel Stadium in Anaheim, California. “When we announced the Pasadena location, we received an overwhelmingly positive response and were completely booked out in a matter of hours. So, we decided to add an additional LA area stop to ensure more people have the opportunity to experience the FIVE,” said…

Continue Reading

WednesdayOct 26, 2022 11:18 am

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Support of EB Awareness Week

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids, today announced that it is supporting initiatives to raise awareness of epidermolysis bullosa, a group of rare genetic connective tissue disorders. Epidermolysis Bullosa Global Awareness Week is Oct. 25-31, 2022. “In severe cases of epidermolysis bullosa, or EB, the very fragile skin tears easily and forms painful blisters and open wounds that do not heal quickly,” said Alexandra Mancini, SVP of Clinical and Regulatory Affairs for InMed. “EB is a very important but rare disease that does not get the attention it deserves. EB Awareness…

Continue Reading

TuesdayOct 25, 2022 10:41 am

TinyGemsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Webcast to Discuss M&A, International Markets

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has scheduled an analyst call for Oct. 26, 2022, at 2 p.m. EST. According to the announcement, the call will focus on the company’s recent M&A activity as well as growth opportunities in the international space. Leadership from Flora Growth, along with Franchise Global Health Inc., will be on the call to discuss the recent definitive agreement that two companies have signed regarding acquisition; discussion will also center on global opportunities within the cannabis industry. Through its subsidiaries, Franchise Global Health is a multinational…

Continue Reading

MondayOct 24, 2022 10:56 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces the I-GO(TM), a Fully EU Homologated Vehicle

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it has secured exclusive sales, distribution and branding rights to the new compact urban delivery electric vehicle, the I-GO, which is fully EU Standard homologated and certified for sale in select European markets. The I-GO bridges the gap between the growing demand for quick deliveries and space constraints found throughout the dense cities of Europe. “Securing the exclusive sales, distribution and branding rights in major European countries for a ready to market electric commercial delivery vehicle is a huge win for the company. The company plans on…

Continue Reading

MondayOct 24, 2022 10:25 am

TinyGemsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Enters into Acquisition Agreement with German-Based Pharmaceutical, Medical Cannabis Distributor

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has inked a definitive agreement with Franchise Global Health Inc. (TSX.V: FGH), a multinational operator in the medical cannabis and pharmaceutical industry. The agreement outlines Flora Growth’s plans to acquire 100% of Franchise Global Health, which has principal operations in Germany, in an all-stock transaction. According to the agreement, the acquisition gives FLGC a foothold in German’s medical cannabis space because FGH’s German businesses service an estimated 1,200 pharmacies in the country; FGH also provides noncannabis medical products to 28 additional countries. In the first…

Continue Reading

FridayOct 21, 2022 11:53 am

TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Announces Key Milestone in Advancing Adimune(TM) Program

Aditxt (NASDAQ: ADTX) is a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system. The company today announced that its program Adimune(TM) has initiated the GMP manufacturing of drug candidate ADI(TM)-100 as a key milestone toward its goal to begin first-in-human trials during the second half of 2023. Pending regulatory approvals, the trials will be performed in autoimmune diseases, first studying psoriasis. Dr. Joachim-Friedrich Kapp, M.D., Ph.D., a 30-year veteran of the pharmaceutical industry and former president of multinational pharmaceutical company Schering AG’s therapeutics business unit, is leading Adimune’s(TM) ADI(TM) immune modulation…

Continue Reading

FridayOct 21, 2022 11:02 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Appoints Former GM Exec as Chief Commercial Officer

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the hiring of John Schwegman as its chief commercial officer (“CCO”) for Mullen’s line of commercial vehicles. Prior to joining Mullen, Schwegman spent 35 years of his career at General Motors (“GM”), holding various executive-level roles and leading global teams across four continents. At GM, he oversaw the growth of commercial product lines, repositioned core brands, developed Chevrolet's core electric vehicle prioritization, relaunched GM’s previously retired medium-duty commercial fleet business and more. “John has tremendous experience in commercial automotive sales, and this makes him a highly strategic addition…

Continue Reading

ThursdayOct 20, 2022 2:21 pm

TinyGemsBreaks – Tingo Inc. (TMNA) Enters Trade Agreement with Nigeria Ag/Commodities Umbrella Organization

Tingo (OTC: TMNA), a leading agri-fintech business in Africa, has signed a trade agreement with the All Farmers Association of Nigeria (“AFAN”). Tingo has signed a merger agreement to be acquired by MICT Inc. (NASDAQ: MICT); AFAN is the umbrella body of the 56 recognized commodities and agricultural associations in Nigeria. According to the agreement, AFAN will add a minimum of 20 million additional subscribers, which would more than triple Tingo Mobile’s current 9.3 million customer base. For its part, Tingo will provide an array of value-added products and services, including Tingo-branded smartphones, access to the Nwassa agri-fintech marketplace platform and…

Continue Reading

Contact us: (512) 354-7000